sorafenib has been researched along with piperine in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (piperine) | Trials (piperine) | Recent Studies (post-2010) (piperine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 923 | 39 | 644 |
| Protein | Taxonomy | sorafenib (IC50) | piperine (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.7665 | |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Homo sapiens (human) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babalghith, AO; El-Far, AH; El-Sewedy, T; El-Shehawy, AA; Elmetwalli, A; Gaber, M; Mahmoud, MA; Mohany, H; Mosallam, SAE; Salama, AF | 1 |
1 other study(ies) available for sorafenib and piperine
| Article | Year |
|---|---|
Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.
Topics: Epigenesis, Genetic; Humans; Liver Neoplasms; MicroRNAs; Molecular Docking Simulation; Sorafenib | 2023 |